Fig. 1From: Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinomaConsort diagram of patient selection. IHC Immunohistochemistry, AIS Adenocarcinoma in situ, MIA Minimally invasive adenocarcinoma, PD-L1 Program death-1 ligand1Back to article page